María Isabel Loza Selected Research

María Isabel Loza Research Topics

Disease

7	Neoplasms (Cancer) 01/2023 - 01/2016
3	Neuroinflammatory Diseases 05/2022 - 01/2017
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2017
2	Neuralgia (Stump Neuralgia) 01/2021 - 01/2019
2	Schizophrenia (Dementia Praecox) 02/2020 - 02/2007
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2012 - 04/2012
1	COVID-19 11/2023
1	Frailty 01/2023
1	Fatty Liver 01/2023
1	Insulin Resistance 01/2023
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Brain Diseases (Brain Disorder) 05/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Pain (Aches) 12/2021
1	Dyskinesias (Dyskinesia) 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2020
1	Autoimmune Diseases (Autoimmune Disease) 12/2020
1	Substance-Related Disorders (Drug Abuse) 02/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2017
1	Ischemic Stroke 02/2016
1	Stroke (Strokes) 02/2016
1	Nervous System Diseases (Neurological Disorders) 10/2012
1	Respiratory Hypersensitivity 03/2011
1	Asthma (Bronchial Asthma) 10/2008

Drug/Important Bio-Agent (IBA)

2	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 01/2016
2	EnzymesIBA 01/2022 - 01/2017
2	Epoxide HydrolasesIBA 01/2022 - 12/2021
2	Analgesics (Analgesic Drugs)IBA 01/2021 - 01/2019
2	CytokinesIBA 12/2020 - 03/2011
2	Type 7 Cyclic Nucleotide PhosphodiesterasesIBA 10/2012 - 04/2012
1	Lipid NanoparticlesIBA 01/2023
1	harmolIBA 01/2023
1	resiquimodIBA 01/2023
1	Gemcitabine FDA Link 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Mannose (D-Mannose)IBA 01/2023
1	Poly I-CIBA 01/2023
1	Protamines (Protamine Sulfate)FDA Link 01/2023
1	ChemokinesIBA 01/2023
1	Small Interfering RNA (siRNA)IBA 01/2023
1	NanocapsulesIBA 01/2023
1	ImidazolinesIBA 05/2022
1	Oxidopamine (6 Hydroxydopamine)IBA 05/2022
1	Guanidine (Guanidine Nitrate)FDA Link 03/2022
1	AcetylcholinesteraseIBA 01/2022
1	6-chlorotacrineIBA 01/2022
1	AcidsIBA 12/2021
1	Daunorubicin (Cerubidine)FDA LinkGeneric 08/2021
1	Levodopa (L Dopa)FDA LinkGeneric 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Interleukin-17 (Interleukin 17)IBA 12/2020
1	LigandsIBA 12/2020
1	Neutralizing AntibodiesIBA 12/2020
1	EndocannabinoidsIBA 02/2020
1	CannabinoidsIBA 02/2020
1	5-HT2C Serotonin ReceptorIBA 02/2020
1	Cisplatin (Platino)FDA LinkGeneric 12/2019
1	imidazoleIBA 01/2017
1	PlatinumIBA 01/2017
1	Glutamic Acid (Glutamate)FDA Link 02/2016
1	polyarginineIBA 01/2016
1	Methacholine Chloride (Methacholine)FDA Link 03/2011
1	Immunoglobulin E (IgE)IBA 03/2011
1	Interleukin-6 (Interleukin 6)IBA 03/2011
1	OvalbuminIBA 03/2011
1	Anti-Asthmatic Agents (Antiasthmatic Drugs)IBA 10/2008
1	Antipsychotic Agents (Antipsychotics)IBA 02/2007
1	Dopamine (Intropin)FDA LinkGeneric 02/2007
1	Serotonin (5 Hydroxytryptamine)IBA 02/2007
1	Neurotransmitter Agents (Neurotransmitter)IBA 02/2007

Therapy/Procedure

4	Therapeutics 11/2023 - 02/2016
2	Aftercare (After-Treatment) 01/2023 - 05/2022
2	Oral Administration 01/2022 - 03/2011
1	Intravenous Administration 01/2023